Louise Raunkilde

4PUBLICATIONS
13CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 30, 2023
Delta tocotrienol as a supplement to FOLFOXIRI in first-line treatment of metastatic colorectal cancer. A randomized, double-blind, placebo-controlled phase II study.

Louise Raunkilde, Torben Frøstrup Hansen, Birgitte Mayland Havelund

|Oct 14, 2022
The Clinical Impact of Methylated Homeobox A9 ctDNA in Patients with Non-Resectable Biliary Tract Cancer Treated with Erlotinib and Bevacizumab.

Line Bechsgaard Andersen, Marit Sofie Kjær Mahler, Rikke Fredslund Andersen

|Sep 23, 2022
NPY Gene Methylation in Circulating Tumor DNA as an Early Biomarker for Treatment Effect in Metastatic Colorectal Cancer.

Louise Raunkilde, Torben Frøstrup Hansen, Rikke Fredslund Andersen

Pageof 1